Liberty Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,765
| Closed | -$221K | – | 153 |
|
|
2022
Q1 | $221K | Buy |
+2,765
| New | +$221K | 0.08% | 135 |
|
|
2021
Q4 | – | Sell |
-431
| Closed | -$34K | – | 281 |
|
|
2021
Q3 | $34K | Buy |
431
+278
| +182% | +$21.9K | 0.01% | 501 |
|
|
2021
Q2 | $13K | Sell |
153
-3
| -2% | -$255 | 0.01% | 584 |
|
|
2021
Q1 | $12K | Hold |
156
| – | – | 0.01% | 553 |
|
|
2020
Q4 | $12K | Hold |
156
| – | – | 0.01% | 548 |
|
|
2020
Q3 | $12K | Sell |
156
-29
| -16% | -$2.23K | 0.01% | 484 |
|
|
2020
Q2 | $23K | Buy |
185
+5
| +3% | +$622 | 0.02% | 356 |
|
|
2020
Q1 | $15K | Sell |
180
-13
| -7% | -$1.08K | 0.01% | 398 |
|
|
2019
Q4 | $16K | Buy |
193
+10
| +5% | +$829 | 0.01% | 443 |
|
|
2019
Q3 | $12K | Sell |
183
-12
| -6% | -$787 | 0.01% | 481 |
|
|
2019
Q2 | $16K | Buy |
195
+54
| +38% | +$4.43K | 0.01% | 444 |
|
|
2019
Q1 | $12K | Buy |
141
+22
| +18% | +$1.87K | 0.01% | 405 |
|
|
2018
Q4 | $10K | Buy |
+119
| New | +$10K | 0.01% | 421 |
|